Meeting
2022 ASCO Annual Meeting
Molecular characteristics of ERBB2-activating mutations in Chinese patients with NSCLC.
Authors
Fan Xu
Affiliated Hospital of Chengde Medical University, Chengde City, China
Fan Xu , Qingshan Li , Wenxin LI , Shenglin Zhang , Yaping Zhao , Didi Guo , Zhongyu Lu , Siqi Chen , Guanghua Lu , Fanfeng Bu , Ran Ding , Wanglong Deng
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Local-Regional Non–Small Cell Lung Cancer
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 8546)
DOI
10.1200/JCO.2022.40.16_suppl.8546
Abstract #
8546
Poster Bd #
173
Abstract Disclosures
Similar Posters
First Author: Russell Madison
Poster
2023 ASCO Annual Meeting
Genomic comparison of MET exon 14 skipping and MET amplified non-small cell lung cancer.
First Author: Rachel Minne
Poster
2022 ASCO Annual Meeting
Molecular characterization of NF1-mutated NSCLC and clinical outcomes.
First Author: Christopher Gates
Poster
2020 ASCO Virtual Scientific Program
Exon-16-skipping ERBB2 (ERBB2ΔEx16) as a novel resistance mechanism against EGFR tyrosine kinase inhibitors in non-small cell lung cancer (NSCLC).
First Author: Xin Zhao